Last reviewed · How we verify

Chelates, Iron

South Valley University · FDA-approved active Small molecule Quality 5/100

Chelates, Iron is a marketed product developed by South Valley University, currently holding an unspecified position in the therapeutic market. The key composition patent for Chelates, Iron is set to expire in 2028, which may provide a period of exclusivity and competitive advantage until then. The primary risk facing Chelates, Iron is the potential for increased competition post-patent expiry in 2028.

At a glance

Generic nameChelates, Iron
Also known asAmino acid chelated iron
SponsorSouth Valley University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: